Esperion Therapeutics
ESPR
#8331
Rank
โ‚ฌ0.14 B
Marketcap
0,74ย โ‚ฌ
Share price
-10.32%
Change (1 day)
-58.68%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of December 2024 : -โ‚ฌ0.34 Billion

According to Esperion Therapeutics's latest financial reports the company has -โ‚ฌ0.34 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$-โ‚ฌ0.38 Billion-9.24%
2023-12-31$-โ‚ฌ0.42 Billion36.36%
2022-12-31$-โ‚ฌ0.31 Billion73.57%
2021-12-31$-โ‚ฌ0.18 Billion122.5%
2020-12-31$-โ‚ฌ78.16 Million-538.87%
2019-12-31$โ‚ฌ17.8 M-74.25%
2018-12-31$โ‚ฌ69.15 M-66.09%
2017-12-31$โ‚ฌ0.20 B-6.17%
2016-12-31$โ‚ฌ0.21 B-17.28%
2015-12-31$โ‚ฌ0.26 B139.25%
2014-12-31$โ‚ฌ0.10 B104.68%
2013-12-31$โ‚ฌ53.65 M-508.1%
2012-12-31$-โ‚ฌ13.15 Million181.88%
2011-12-31$-โ‚ฌ4.67 Million
2002-12-31$โ‚ฌ37.06 M-50.78%
2001-12-31$โ‚ฌ75.29 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ0.22 B-167.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.91 B-1,555.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ76.85 B-22,866.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.49 B-7,651.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.16 B-149.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.12 B-137.55%๐Ÿ‡บ๐Ÿ‡ธ USA